Archive: 20/02/2017
Study shows strong long-term survival rates for patients with GIST
Nine years ago, SWOG researchers confirmed a new standard of care for patients with incurable gastrointestinal stromal tumors (GIST), who could survive by being treated with imatinib mesylate, the breakthrough drug marketed ...
Feb 20, 2017
Many cancer survivors change their prescription drug use for financial reasons
A new analysis indicates that many cancer survivors change their prescription drug use (including skipping doses or requesting cheaper medications) for financial reasons. Published early online in Cancer, a peer-reviewed ...
Feb 20, 2017